{"schema_version":"1.0","type":"article","title":"AI三巨頭在醫藥裡廝殺","url":"https://drugnews.com.tw/articles/2026-04-22-ai.html","markdown_url":"https://drugnews.com.tw/articles/2026-04-22-ai.md","lang":"zh-Hant","date":"2026-04-22","publish_at":"2026-04-22T10:30:00+08:00","updated_at":"2026-04-22","category":"商業分析系列","topic":"商業分析系列","tags":["商業分析系列","免費文章","AI","BD","臨床數據","生技投資","製藥巨頭"],"summary":"ChatGPT、Claude、Gemini 這三大通用大模型，現在打的已經不只是消費端流量，也不是一般企業辦公市場，而是開始往生醫製藥產業鏈的深水區插旗。","key_points":[],"facts":[],"sections":[],"references":[{"title":"[0]: 各公司官網＆公開資料","source":"","date":"","url":""},{"title":"[1]:","source":"","date":"","url":""},{"title":"Advancing Claude in healthcare and the life sciences \\ Anthropic","source":"","date":"","url":""},{"title":"![Dcard 原圖：AI三巨頭在醫藥裡廝殺（圖 3）](images/dcard-03.webp","source":"","date":"","url":""},{"title":"Introducing Claude for Healthcare with HIPAA-ready infrastructure, plus expanded Life Sciences tools for clinical trials and regulatory submissions. New connectors to CMS, Medidata, and ClinicalTrials.gov.","source":"","date":"","url":""},{"title":"www.anthropic.com","source":"","date":"","url":""},{"title":"[2]:","source":"","date":"","url":""},{"title":"Claude for Life Sciences \\ Anthropic","source":"","date":"","url":""},{"title":"Discover how Claude accelerates life sciences research with new scientific connectors, skills, and improved performance for drug discovery and clinical work.","source":"","date":"","url":""},{"title":"www.anthropic.com","source":"","date":"","url":""},{"title":"[3]:","source":"","date":"","url":""},{"title":"Anthropic acquires stealth startup Coefficient Bio in $400M deal","source":"","date":"","url":""},{"title":"AI powerhouse Anthropic is acquiring of previously stealth AI startup Coefficient Bio in a $400 million stock deal.","source":"","date":"","url":""},{"title":"![Dcard 原圖：AI三巨頭在醫藥裡廝殺（圖 4）](images/dcard-04.webp","source":"","date":"","url":""},{"title":"www.fiercebiotech.com","source":"","date":"","url":""},{"title":"[4]:","source":"","date":"","url":""},{"title":"Isomorphic Labs kicks off 2024 with two pharmaceutical collaborations - Isomorphic Labs","source":"","date":"","url":""},{"title":"Isomorphic Labs announces strategic collaborations with two of the world’s leading pharmaceutical companies, Eli Lilly and Company and Novartis. These partnerships have the potential to be worth nearly $3 billion to Isomorphic Labs, excluding any royaltie","source":"","date":"","url":""},{"title":"www.isomorphiclabs.com","source":"","date":"","url":""},{"title":"[5]:","source":"","date":"","url":""},{"title":"Advancing medical AI with Med-Gemini","source":"","date":"","url":""},{"title":"https://research.google/blog/advancing-medical-ai-with-med-gemini/","source":"","date":"","url":"https://research.google/blog/advancing-medical-ai-with-med-gemini/"},{"title":"research.google","source":"","date":"","url":""},{"title":"[6]:","source":"","date":"","url":""},{"title":"Moderna","source":"","date":"","url":""},{"title":"Accelerating the development of life-saving treatments.","source":"","date":"","url":""},{"title":"openai.com","source":"","date":"","url":""},{"title":"[7]:","source":"","date":"","url":""},{"title":"Sanofi","source":"","date":"","url":""},{"title":"Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration Paris, New York, N.Y., and San Francisco, CA, May 21, 2024. Sanofi, Formation Bio and OpenAI are collaborating to build...","source":"","date":"","url":""},{"title":"www.sanofi.com","source":"","date":"","url":""},{"title":"![Dcard 原圖：AI三巨頭在醫藥裡廝殺（圖 5）](images/dcard-05.png","source":"","date":"","url":""}],"images":[{"alt":"Dcard 原圖：AI三巨頭在醫藥裡廝殺（圖 1）","url":"https://drugnews.com.tw/assets/articles/ai/dcard-01.webp"},{"alt":"Dcard 原圖：AI三巨頭在醫藥裡廝殺（圖 2）","url":"https://drugnews.com.tw/assets/articles/ai/dcard-02.webp"},{"alt":"Dcard 原圖：AI三巨頭在醫藥裡廝殺（圖 3）","url":"https://drugnews.com.tw/assets/articles/ai/dcard-03.webp"},{"alt":"Dcard 原圖：AI三巨頭在醫藥裡廝殺（圖 4）","url":"https://drugnews.com.tw/assets/articles/ai/dcard-04.webp"},{"alt":"Dcard 原圖：AI三巨頭在醫藥裡廝殺（圖 5）","url":"https://drugnews.com.tw/assets/articles/ai/dcard-05.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/ai/dcard-01.webp","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-04-22）。AI三巨頭在醫藥裡廝殺。https://drugnews.com.tw/articles/2026-04-22-ai.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{"en":"2026-04-22-ai-en.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}